Immunocompromised Individuals

COVID-19 Vaccines: Immunocompromised Individuals

Considerations for COVID-19 Vaccination in Immunocompromised Patients (April 22, 2022)
Reference this FAQ about the use and safety of COVID-19 vaccines vaccine in immunocompromised individuals, including key differences in dosing schedules. (APhA Know the Facts – HTML)
Self-Attestation Statements for COVID-19 Recipients Download or edit a patient attestation form from the options below to provide to patients requesting an additional dose of mRNA COVID-19 vaccine.
1. Detailed patient attestation using patient friendly definition of moderately or severely immunocompromised individuals – (PDF)(Word)
2. Concise patient attestation for moderately or severely immunocompromised individuals – (PDF)(Word)
3. Detailed patient attestation using formal definition of moderately or severely immunocompromised individuals – (PDF)(Word)